Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single-center study.

Hideto KawarataniYuki TsujiKoji IshidaDaisuke KayaTakuya KuboYukihisa FujinagaYasuhiko SawadaShinya SatoHiroaki TakayaKosuke KajiTadashi NamisakiKei MoriyaTakemi AkahaneHitoshi Yoshiji

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)

Repeated treatment of lusutrombopag is effective for CLD patients with thrombocytopenia. Moreover, three or more treatments with lusutrombopag showed equal effect compared with one and two treatments with the medication.

Keyphrases

healthcare
emergency department
adverse drug
electronic health record